MedPath

辽宁民康制药有限公司

Ownership
-
Established
2007-08-17
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

41

NMPA:41

Drug Approvals

Compound Sodium Acetate Ringer's Injection

Product Name
复方醋酸钠林格注射液
Approval Number
国药准字H20254344
Approval Date
May 27, 2025
NMPA

Compound Sodium Acetate Ringer's Injection

Product Name
复方醋酸钠林格注射液
Approval Number
国药准字H20254345
Approval Date
May 27, 2025
NMPA

Multiple Electrolytes Injection

Product Name
复方电解质注射液
Approval Number
国药准字H20253656
Approval Date
Mar 18, 2025
NMPA

Sodium Bicarbonate Injection

Product Name
碳酸氢钠注射液
Approval Number
国药准字H20247327
Approval Date
Dec 24, 2024
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H20249307
Approval Date
Nov 5, 2024
NMPA

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20249094
Approval Date
Oct 16, 2024
NMPA

Sodium Chloride Physiological Solution

Product Name
生理氯化钠溶液
Approval Number
国药准字H20249095
Approval Date
Oct 16, 2024
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20247050
Approval Date
May 8, 2024
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20247051
Approval Date
May 8, 2024
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20247047
Approval Date
May 8, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.